mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.007 |
mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.009 |
mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.009 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.01 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.02 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.02 |